Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-19

Clinical Trial Update: Urinary Steroid Metabolites in Autism

View source ↗

Summary

This is an update on a clinical trial studying urinary steroid metabolites in individuals with autism spectrum disorders; the trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intersci Research Association, Austria | Conditions: Autism, Autism Spectrum Disorder | Status: UNKNOWN